MedTrace Logo

Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access

NCT05124184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 356

Last updated 2025-05-09

Study results available
· View outcomes & findings →

Summary

This multicenter, single-arm retrospective registry (chart review) is being conducted to confirm the clinical performance and safety of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft throughout the device functional lifetime for each indication area.

Conditions

  • PAD - Peripheral Arterial Disease
  • AAA - Abdominal Aortic Aneurysm
  • End-Stage Renal Disease

Interventions

DEVICE

GORE® PROPATEN® Vascular Graft

Patients that have had treatment with GORE® PROPATEN® Vascular Graft

DEVICE

GORE-TEX® Vascular Grafts

Patients that have had treatment with GORE-TEX® Vascular Grafts

Sponsors & Collaborators

  • W.L.Gore & Associates

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-24
Primary Completion
2024-07-22
Completion
2024-07-22

Countries

  • France
  • Italy
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05124184 on ClinicalTrials.gov